ROCKEFELLER CAPITAL MANAGEMENT L.P. – Regeneron Pharmaceuticals, Inc. Transaction History
ROCKEFELLER CAPITAL MANAGEMENT L.P. portfolio value:
$55.73M
portfolio value
ROCKEFELLER CAPITAL MANAGEMENT L.P. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -1.03% | -840 shares | 7.41M | $688.87 | 80.90K |
Q2 2022 | share | Decrease | -10.81% | -9.90K shares | -15.68M | $591.13 | 81.74K |
Q1 2022 | share | Increase | +6.37% | 5.49K shares | 9.6M | $698.42 | 91.65K |
Q4 2021 | share | Decrease | -1.34% | -1.17K shares | 1.56M | $642.51 | 86.16K |
Q3 2021 | share | Decrease | -53.97% | -102.41K shares | -53.13M | $605.18 | 87.33K |
Q2 2021 | share | Increase | +49.11% | 62.49K shares | 45.77M | $558.54 | 189.75K |
Q1 2021 | share | Increase | +17.15% | 18.63K shares | 7.73M | $473.14 | 127.25K |
Q4 2020 | share | Increase | +3.86% | 4.04K shares | -6.06M | $483.11 | 108.62K |
Q3 2020 | share | Decrease | -20.65% | -27.21K shares | -23.65M | $559.78 | 104.58K |
Q2 2020 | share | Decrease | -2.01% | -2.71K shares | 16.51M | $623.65 | 131.79K |
Q1 2020 | share | Decrease | -13.33% | -20.68K shares | 7.40M | $488.29 | 134.50K |
Q4 2019 | share | Decrease | -34.52% | -81.82K shares | -7.47M | $375.48 | 155.19K |
Q3 2019 | share | Decrease | -1.48% | -3.56K shares | -9.55M | $277.4 | 237.01K |
Q2 2019 | share | Increase | +70.59% | 99.54K shares | 17.39M | $313 | 240.57K |
Q1 2019 | share | Decrease | -1.05% | -1.49K shares | 4.67M | $410.62 | 141.03K |
Q4 2018 | share | Decrease | -18.45% | -32.24K shares | -17.38M | $373.5 | 142.52K |
Q3 2018 | share | Decrease | -1.00% | -1.76K shares | 9.71M | $404.04 | 174.77K |
Q2 2018 | share | Decrease | -1.07% | -1.90K shares | -545K | $344.99 | 176.53K |
Q1 2018 | share | Increase | 0.00% | 178.43K shares | 61.44M | $344.36 | 178.43K |